Type 1 Diabetes

🧠 Standard of Care

Type 1 Diabetes (T1D) is an autoimmune condition where the pancreas produces little to no insulin. Lifelong management requires careful monitoring of blood glucose levels to prevent acute complications (hypoglycemia/DKA) and long-term organ damage.

• Continuous Glucose Monitoring (CGM): Wearable sensors that provide real-time blood sugar readings, reducing the need for finger pricks and alerting patients to dangerous highs or lows.
• Carbohydrate Counting: Essential for calculating meal-time insulin doses to maintain tight glycemic control.
• Endocrinologist Care: Regular visits to review A1C levels, adjust insulin ratios, and screen for complications (retinopathy, neuropathy, nephropathy).

💊 Insulin Therapy and Devices

Because the body cannot produce insulin, exogenous insulin must be administered via injections or pumps.

Insulin Delivery Systems

Multiple Daily Injections (MDI) involve using long-acting basal insulin and rapid-acting bolus insulin for meals. Alternatively, Insulin Pumps deliver rapid-acting insulin continuously, offering more flexibility.

Automated Insulin Delivery (AID) / Closed-Loop Systems

These advanced systems link a CGM directly to an insulin pump. An algorithm automatically adjusts background insulin delivery based on sensor readings, functioning as an "artificial pancreas."

💉 Emerging Therapies

Beyond traditional insulin replacement, researchers are exploring ways to preserve remaining beta cells and address the underlying autoimmunity.

• Disease-Modifying Therapies (Teplizumab): Recently approved for delaying the onset of Stage 3 T1D in high-risk individuals by modulating the immune system's attack on beta cells.
• Islet Cell Transplantation: An experimental procedure where healthy insulin-producing cells from a donor are implanted into the patient's liver, often requiring immunosuppressants.

🔬 Active Clinical Trials

Researchers are actively testing new interventions to improve care and find a cure. Here are some live trials actively recruiting participants:

• NCT03369821 (University of Exeter): The EXE-T1D study focusing on understanding beta-cell destruction through the study of extremely early-onset Type 1 Diabetes.
• NCT07059806 (Yale University): T1CARE, a randomized trial of a novel intervention to address social determinants of health in young adults with Type 1 Diabetes.
• NCT05610865 (University of the Punjab): Exploring the efficacy of adipose tissue-derived stem cells for the treatment of diabetic foot ulcers.

🥗 Dietary Management and Carbohydrate Counting

Because insulin doses are directly tied to food intake, precise dietary management is critical for individuals with Type 1 Diabetes.

• Carbohydrate Counting: This is the most common meal planning technique. Patients learn to estimate the number of grams of carbohydrates in their meals to calculate the exact dose of rapid-acting insulin required to cover the food.
• Insulin-to-Carb Ratio (ICR): A personalized ratio prescribed by an endocrinologist indicating how many grams of carbohydrates are covered by one unit of insulin.
• Glycemic Index (GI): Choosing complex, low-GI carbohydrates (like whole grains, beans, and non-starchy vegetables) helps prevent rapid spikes in blood sugar compared to high-GI foods like sugary drinks and white bread.

❓ Patient FAQ

Q: What is the difference between Type 1 and Type 2 Diabetes?
A: Type 1 is an autoimmune disease where the body attacks its own insulin-producing cells. Type 2 is a metabolic condition characterized by insulin resistance and relative insulin deficiency, often linked to lifestyle factors.

Q: Can diet and exercise cure Type 1 Diabetes?
A: No. While a healthy diet and regular exercise are crucial for managing blood sugar levels and overall health, they cannot cure T1D or eliminate the need for insulin therapy.

Q: What is an A1C test?
A: The A1C test measures your average blood sugar levels over the past 2-3 months. It provides a broader picture of glycemic control than daily finger pricks.